Filing Details

Accession Number:
0001708138-20-000012
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-02-26 18:14:57
Reporting Period:
2020-02-24
Accepted Time:
2020-02-26 18:14:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
872589 Regeneron Pharmaceuticals Inc. REGN Pharmaceutical Preparations (2834) 133444607
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1585160 E Robert Landry 777 Old Saw Mill River Road
Tarrytown NY 10591
Evp Finance Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-02-24 1,000 $272.70 25,973 No 4 M Direct
Common Stock Disposition 2020-02-24 786 $406.59 25,187 No 4 F Direct
Common Stock Acquisiton 2020-02-25 1,000 $272.70 26,187 No 4 M Direct
Common Stock Disposition 2020-02-25 800 $447.30 25,387 No 4 F Direct
Common Stock Disposition 2020-02-25 10 $438.00 25,377 No 4 S Direct
Common Stock Disposition 2020-02-25 12 $444.03 25,365 No 4 S Direct
Common Stock Disposition 2020-02-25 11 $445.35 25,354 No 4 S Direct
Common Stock Disposition 2020-02-25 37 $447.11 25,317 No 4 S Direct
Common Stock Disposition 2020-02-25 18 $448.54 25,299 No 4 S Direct
Common Stock Disposition 2020-02-25 54 $449.50 25,245 No 4 S Direct
Common Stock Disposition 2020-02-25 35 $450.80 25,210 No 4 S Direct
Common Stock Disposition 2020-02-25 16 $453.60 25,194 No 4 S Direct
Common Stock Disposition 2020-02-25 4 $454.67 25,190 No 4 S Direct
Common Stock Disposition 2020-02-25 17 $455.13 25,173 No 4 S Direct
Common Stock Disposition 2020-02-26 10 $452.04 25,163 No 4 S Direct
Common Stock Disposition 2020-02-26 44 $453.36 25,119 No 4 S Direct
Common Stock Disposition 2020-02-26 18 $454.85 25,101 No 4 S Direct
Common Stock Disposition 2020-02-26 32 $455.37 25,069 No 4 S Direct
Common Stock Disposition 2020-02-26 10 $456.67 25,059 No 4 S Direct
Common Stock Disposition 2020-02-26 25 $457.23 25,034 No 4 S Direct
Common Stock Disposition 2020-02-26 27 $458.35 25,007 No 4 S Direct
Common Stock Disposition 2020-02-26 34 $460.05 24,973 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 M Direct
No 4 F Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2020-02-24 1,000 $0.00 1,000 $272.70
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2020-02-25 1,000 $0.00 1,000 $272.70
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
55,500 2023-09-09 No 4 M Direct
54,500 2023-09-09 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 172 Indirect By 401(k) Plan
Footnotes
  1. Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
  2. Represents volume-weighted average price of sales of 37 shares of Company stock on February 25, 2020 at prices ranging from $447.00 to $447.24. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 25, 2020 at each separate price.
  3. Represents volume-weighted average price of sales of 54 shares of Company stock on February 25, 2020 at prices ranging from $449.01 to $449.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 25, 2020 at each separate price.
  4. Represents volume-weighted average price of sales of 35 shares of Company stock on February 25, 2020 at prices ranging from $450.70 to $450.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 25, 2020 at each separate price.
  5. Represents volume-weighted average price of sales of 44 shares of Company stock on February 26, 2020 at prices ranging from $453.04 to $453.78. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 26, 2020 at each separate price.
  6. Represents volume-weighted average price of sales of 32 shares of Company stock on February 26, 2020 at prices ranging from $455.24 to $455.49. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 26, 2020 at each separate price.
  7. Represents volume-weighted average price of sales of 25 shares of Company stock on February 26, 2020 at prices ranging from $457.10 to $457.65. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 26, 2020 at each separate price.
  8. Represents volume-weighted average price of sales of 27 shares of Company stock on February 26, 2020 at prices ranging from $458.11 to $458.77. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 26, 2020 at each separate price.
  9. Represents volume-weighted average price of sales of 34 shares of Company stock on February 26, 2020 at prices ranging from $460.03 to $460.07. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 26, 2020 at each separate price.
  10. The stock option award vests in four equal annual installments, commencing one year after the date of grant.